A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

Covid Flu A/B and RSV 4 in 1 Diagnostic Test

NCT07308158 ·Status: COMPLETED

FLU A+B Nasal Swab Clinical Study

NCT00636662 ·Status: COMPLETED

Characterizing the Human Airway Immune Response to FluMist Vaccination

NCT07177417 ·Status: RECRUITING ·Phase: PHASE4

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

NCT00706563 ·Status: COMPLETED ·Phase: PHASE3

Collection and Extraction of Respiratory Specimens

NCT01083511 ·Status: COMPLETED

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

NCT00782431 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

NCT06602531 ·Status: COMPLETED ·Phase: PHASE1

Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B

NCT02767414 ·Status: COMPLETED ·Phase: NA

A/Texas Flu Challenge

NCT06753474 ·Status: RECRUITING ·Phase: PHASE1

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

NCT00800605 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza

NCT00706732 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

NCT07019883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

NCT06602024 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

NCT00345904 ·Status: COMPLETED ·Phase: PHASE3

Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

NCT03248960 ·Status: COMPLETED ·Phase: NA

Respiratory Virus Hospitalization Study (FLU 003 Plus)

NCT01056185 ·Status: COMPLETED

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921 ·Status: UNKNOWN ·Phase: NA

Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain

NCT06613737 ·Status: COMPLETED ·Phase: NA

Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™

NCT00377611 ·Status: COMPLETED ·Phase: PHASE4

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763 ·Status: COMPLETED ·Phase: PHASE2

Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine

NCT01023776 ·Status: COMPLETED ·Phase: PHASE4

Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction

NCT03595358 ·Status: COMPLETED ·Phase: NA

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

NCT00984451 ·Status: COMPLETED

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

NCT02846311 ·Status: COMPLETED

Universal Influenza A Vaccine in Healthy Adults

NCT05155319 ·Status: COMPLETED ·Phase: PHASE1